United Biomedical Competitors and Similar CompaniesClear all

United Biomedical's competitors and similar companies include AustinPx, Kamada Pharmaceuticals, Camurus and Sosei Heptares.

	United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.	AustinPx AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble drug molecules.	Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.	Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.	Sosei Heptares Sosei Heptares is a biopharmaceutical company that specializes in drug development.
Founding Date	Founding Date 1985	Founding Date 2007	Founding Date 1990	Founding Date 1991	Founding Date 1990
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Hauppauge, US HQ Lanzhou, CN Yangzhou Shi, CN see more	Locations Georgetown, US HQ	Locations Rehovot, IL HQ Beit Kama, IL	Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB	Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB
Employees	Employees 45	Employees 412% decrease	Employees 420	Employees 265	Employees 387
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 317 m	Valuation ($) 3.4 b	Valuation ($) 697 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $180.5m (FY, 2025)	Revenue (est.) kr2.3b (FY, 2025)	Revenue (est.) ¥29.6b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $72.1m (FY, 2025)	Cost of goods kr138.7m (FY, 2025)	Cost of goods ¥7.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $108.4m (FY, 2025)	Gross profit kr2.1b (FY, 2025)	Gross profit ¥24b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income $20.2m (FY, 2025)	Net income kr735.6m (FY, 2025)	Net income (¥12.5b) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 52.7m	Total funding raised $ 90m	Total funding raised N/A	Total funding raised $ 65m

For sources of this data, please see the company profile

View Company Profiles

AustinPx

Georgetown, US

Employees

41↓ 2% decrease

AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble drug molecules.

View company

Kamada Pharmaceuticals

Rehovot, IL

Employees

420

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company

Camurus

Lund, SE

Employees

265

Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.